Lyora Therapeutics raises $2.5M pre seed

◆ Amount

$2.5M

◆ Announced

15 Jul 2026

◆ Company

◆ Source

◆ The Round

Lyora Therapeutics raised $2.5M in pre seed funding, announced on 15 July 2026. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

◆ About Lyora Therapeutics

Biotech company developing genetic medicines targeting the root cause of inherited retinal diseases. Lyora Therapeutics is based in United States and currently at pre seed stage, operating in Biotech.

◆ Market context

This funding event is a citable node in Fusion42's market graph: it links Lyora Therapeutics's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.

◆ Explore the market